New Orleans, LA6 Active Studies

Lupus Clinical Trials in New Orleans, LA

Find 6 actively recruiting lupus clinical trials in New Orleans, LA. Connect with local research sites and explore new treatment options.

6
Active Trials
6
Sponsors
720
Enrolling

Recruiting Lupus Studies in New Orleans

NCT06570798Recruiting

A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...

New Orleans, LAPHASE2220 participantsAmgen
View Study Details
NCT06232304Recruiting

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSL...

New Orleans, LANA175 participantsMichigan State University
View Study Details
NCT06557265Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells ...

New Orleans, LAPHASE1120 participantsNkarta, Inc.
View Study Details
NCT05835310Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE...

New Orleans, LAPHASE3100 participantsAstraZeneca
View Study Details
NCT06925542Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including ac...

New Orleans, LAPHASE180 participantsCRISPR Therapeutics
View Study Details
NCT06008626Recruiting

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

This is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in pati...

New Orleans, LANA25 participantsCryosa, Inc.
View Study Details

About Lupus Clinical Trials in New Orleans

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 6 lupus clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 720 participants. Research is being sponsored by Amgen, Michigan State University, Nkarta, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in New Orleans — FAQ

Are there lupus clinical trials in New Orleans?

Yes, there are 6 lupus clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What lupus treatments are being tested?

The 6 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated July 18, 2026 from ClinicalTrials.gov